NCT02824757 The Effects of Glucocorticoids on Glucose Metabolism in Patients With Interstitial Lung Disease Status UNKNOWN Phase N/A
NCT02821689 Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis Status UNKNOWN Phase PHASE4
NCT02813447 Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD) Status TERMINATED Phase NA
NCT02748798 Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders Status TERMINATED Phase EARLY_PHASE1
NCT02633293 An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE Status TERMINATED Phase PHASE2/PHASE3
NCT02630316 Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE Status COMPLETED Phase PHASE2/PHASE3
NCT02622412 Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease Status COMPLETED Phase NA
NCT02622022 Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease Status COMPLETED Phase PHASE4
NCT02615938 Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD) Status TERMINATED Phase PHASE2
NCT02594839 Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02563730 Open Label Trial of Utility of Cryobiopsy in the Multidisciplinary Diagnosis of Idiopathic Interstitial Lung Disease Status UNKNOWN Phase NA
NCT02497144 Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease Status COMPLETED Phase NA
NCT02426229 Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma Status COMPLETED Phase PHASE1
NCT02278107 Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease Status UNKNOWN Phase NA
NCT02235779 Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases Status UNKNOWN Phase NA